A Novel Approach to New Family-Forms, Assisted Reproductive Technologies and Transnationalism.

Summary

More and more people are using medical help to have children, like IVF or egg donation. But the experience can be very different depending on where you live, who you are, and the kind of support you get.

We want to talk to families, doctors, and people who work at support organizations to learn how these experiences are changing what family means today. We’re interested in how people get these services, what problems they face, and how it affects the way families are made.

In Alberta, we especially want to hear from people who have used fertility treatments. We also want to speak with doctors, nurses, and support workers.

Your stories will help us understand what’s working, what needs to change, and how we can make things better for others going through the same journey.

Eligibility

Currently recruiting participants: Yes

Eligible ages: 7 to 99

Accepts healthy participants: Yes

Inclusion criteria:

You can take part if you meet one or more of the following:

You are 18 years or older and part of a family that has used fertility treatments (like IVF with sperm or egg donation, embryo donation and surrogacy ).

You are the parent or guardian of a child who is 7 years or older, and your family has used fertility treatments.

You are a doctor, nurse, or healthcare worker who helps people with fertility care.

You work or volunteer for a group or organization that supports people going through fertility treatments.

You live in Alberta.

Participate

Fill out the following form if you want to participate in this research

Method of contact

Collection of personal information
Your personal information is collected under the authority of section 33(c) of the Freedom of Information and Protection of Privacy Act. If you have any questions about the collection or use of this information, please visit our Access to Information page.

Additional information

Contact information

Anna Bettini Postdoctoral Research Associate, University of Calgary

Principal investigator:

Petra Dolata

Clinical trial:

No

REB-ID:

REB25-0611